Ozari vs Walgreens Weight Management: $49 Visits, $149 Pills, $349 Refills

August 31, 2026. That is the printed expiration date on the $149/month Wegovy pill price Walgreens has been advertising — and it is four weeks away as this publishes. Walgreens Weight Management is one of the most transparent GLP-1 programs on the market about its numbers. Those numbers just happen to come with footnotes, dose tiers, and calendar deadlines.

What Walgreens Publicly Lists

Walgreens Weight Management is a telehealth arm of Walgreens Virtual Healthcare, launched broadly in early 2026. It sells only FDA-approved branded medication — no compounded GLP-1s — filled through Walgreens Pharmacy. From its own weight-loss page, current as of August 2026:

• Visits: $49 for the initial video visit; follow-up chat or video visits are $49 each. No subscription or membership fee.
• Wegovy pills (oral semaglutide): $149/month for the two lowest doses through August 31, 2026, via a Novo Nordisk self-pay offer. Higher doses run up to $299/month.
• Wegovy injectables: $199 per fill for the first two fills (0.25 mg and 0.5 mg) through December 31, 2026, then $349/month.
• Foundayo (orforglipron) pills: from $149/month for 0.8 mg; $199 for 2.5 mg; $299 for higher doses; regular prices reach $349.
• Zepbound (tirzepatide) KwikPens: regular prices from $299 (2.5 mg) to $699/month, with a Lilly offer holding the 7.5–15 mg doses at $449.
• Availability: 28 states listed in the page's disclaimer, not all 50. Insurance and Medicare are not handled through the telehealth program.

That is real disclosure. The pharmacy is named (it's Walgreens), the medications are FDA-approved, and every promo has its end date printed. The trade-off is dose-tier pricing: your monthly cost climbs as your dose does, and most GLP-1 protocols titrate upward through year one.

How the Models Compare

Walgreens unbundles everything. Visits are pay-per-use at $49. Medication is priced per product, per dose, per manufacturer offer. For someone who wants FDA-approved branded medication, monthly follow-ups they control, and a pharmacy with a storefront on the corner, this model is honest and flexible. Nobody bills you a membership while you think it over.

The catch is trajectory. The advertised prices sit at the lowest doses, where patients start — not where most stay. A Wegovy injectable patient begins at $199 and, per the published offer terms, lands at $349/month from fill three onward.

Ozari bundles instead. One flat price covers the compounded medication, provider review, and shipping: semaglutide on Ozari One at $86/mo billed quarterly, or Ozari Select at $145/mo quarterly or $175/mo monthly; tirzepatide on Ozari One at $125/mo billed quarterly, or Ozari Select at $199/mo quarterly or $235/mo monthly. The price does not climb with dose. There is no membership fee, HSA/FSA cards are accepted, medications come from licensed 503A US compounding pharmacies, and intake confirms availability across all 50 states. Ozari One ships to every state except California; California patients use Ozari Select, $145/mo billed quarterly for semaglutide or $199/mo for tirzepatide. The trade-off runs the other way: compounded medications are not FDA-approved, which is a real distinction Walgreens holds in its favor.

The 12-Month Math

Ozari semaglutide:

• Ozari One semaglutide: $258 every 3 months (about $86/mo)
• Four shipments: $258 × 4 = $1,032
• Year one: $1,032

Ozari One tirzepatide: $375 every 3 months, $375 × 4 = $1,500. Year one: $1,500.

Walgreens, using its published self-pay figures:

• Wegovy injectable path: $199 × 2 = $398, then $349 × 10 = $3,490. Add the $49 initial visit and, say, three $49 follow-ups ($196 total in visits). Year one: roughly $4,084.
• Wegovy pill path, best case: $149 × 12 = $1,788 — but only if you stay on the lowest doses and the promo pricing extends past its August 31, 2026 window. A realistic titration to the $299 tier looks more like $149 × 3 + $299 × 9 = $447 + $2,691 = $3,138, plus visits.
• Zepbound path: $299 to $699/month by dose; a titrating year plausibly exceeds $5,000.

Against Ozari One's $1,032 semaglutide year, the published Wegovy injectable path costs roughly $3,050 more ($4,084 − $1,032 = $3,052). The comparison is branded-versus-compounded, not like-for-like — but the dollar gap is what it is.

A note from Johanna Galyen, APRN, FNP: Dose-tiered pricing tempts people to do something we ask you not to do: stay at a lower dose than prescribed, or split fills, to hold a cheaper tier. Titration schedules exist because they manage side effects and build effect — let cost drive your choice of program, not your dose. And if you change between a branded product and a compounded one in either direction, that change belongs in a prescriber conversation, with no overlapping injections during the handoff.

Key Comparison Table

Before you pay any provider, check it against the eight red flags that rule out a GLP-1 provider.

Walgreens and Ozari both clear this list. Whoever you compare, walk away from providers that:

• Sell GLP-1s with no prescription or provider review
• Advertise "generic Ozempic" — no US generic semaglutide exists
• Claim compounded medications are FDA-approved
• Won't name the dispensing pharmacy
• Ship "research use only" peptides for human use
• Guarantee a specific number of pounds lost

How to Cancel Walgreens Weight Management

There is no subscription to cancel. Walgreens Weight Management bills $49 per visit with no membership, per Walgreens' published program terms as of August 2026 — so stopping means simply not booking another appointment. No notice period, no recurring program charge, nothing to call about. Two loose ends still deserve attention. First, if your Wegovy or Zepbound prescription was set up on auto-refill at Walgreens Pharmacy, turn that off in your Walgreens account or ask the pharmacy to stop refills; otherwise fills can keep coming while refills remain on the prescription. Second, the manufacturer self-pay offers behind the $149–$449 prices — Novo Nordisk's Wegovy pricing and Lilly's Zepbound offers — are separate enrollments with their own terms; if you signed up for one, check whether it involves any recurring arrangement and unenroll through that program directly. Ask the pharmacy to confirm in writing that no refills remain active, and screenshot that confirmation for your records. Ozari publishes its cancellation terms at https://www.ozarihealth.com/refund-policy

Frequently Asked Questions

How much does Walgreens Weight Management cost?

$49 per telehealth visit, no subscription. Medication is separate: Wegovy pills from $149/month (promo through Aug 31, 2026), injectables $199 for two fills then $349/month, Zepbound $299–$699/month by dose.

Does Walgreens sell compounded semaglutide?

No. The program prescribes only FDA-approved branded medications — Wegovy, Zepbound, Foundayo, and Saxenda — filled through Walgreens Pharmacy at manufacturer savings-card prices.

Is Walgreens Weight Management available in every state?

No. Its own disclaimer lists 28 states as of August 2026. Ozari confirms availability across all 50 states through its intake process.

Why do Walgreens' prices increase mid-year?

Two reasons: manufacturer promos expire on printed dates, and pricing is dose-tiered. Standard titration moves patients into higher-priced tiers within months.

How does Ozari keep one flat price?

Compounded semaglutide and tirzepatide from licensed 503A US pharmacies are priced per plan, not per dose (Ozari One semaglutide $86/mo billed quarterly; Ozari Select $145/mo quarterly or $175/mo monthly), with provider review and shipping included.

Which is right for me?

That is a clinical and financial question. Branded FDA-approved medication has clear advantages; compounded pricing has others. Discuss both with a licensed provider and verify current prices directly.

How do I cancel Walgreens Weight Management?

There is nothing to cancel — it is $49 per visit with no subscription, so you just stop booking visits. Do separately turn off pharmacy auto-refill and unenroll from any Wegovy or Zepbound manufacturer savings offer you joined.

Is Walgreens Weight Management legitimate?

Walgreens Weight Management requires licensed provider review and discloses that compounded medications are not FDA-approved, per its published pages. Walgreens Weight Management states it holds LegitScript certification; you can confirm that at legitscript.com and check its pharmacy licensure before ordering.

This article is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Ozari Health connects patients with licensed independent providers who determine whether treatment is appropriate.

Sources

• https://www.walgreens.com/topic/virtual-healthcare/weight-loss.jsp
• https://www.walgreens.com/topic/virtual-healthcare/weight-loss/wegovy.jsp
• https://corporate.walgreens.com/news-and-stories/press-releases/pharmacy-healthcare/virtual-healthcare-adds-weight-management-services/
• https://hitconsultant.net/2026/03/09/walgreens-weight-management-glp-1-telehealth-subscription-free/
• https://www.ozarihealth.com/true-cost/walgreens-weight-management
• https://www.ozarihealth.com/compounded-semaglutide
• https://www.ozarihealth.com/compounded-tirzepatide
• https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
• https://huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026